Navigation Links
Discovering a 'THRIL' that correlates with severity of Kawasaki disease
Date:12/26/2013

LA JOLLA, Calif., December 26, 2013 Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cellsmacrophagesare stimulated in response to pathogens. The molecule, termed "THRIL," helps regulate the immune response and shows an association with Kawasaki disease. The findings suggest that THRIL may contribute to other inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The study, published online in Proceedings of the National Academy of Sciences, measured large intergenic noncoding RNA (lincRNA) produced when the immune system is activated. One lincRNA was found to bind heterogenous nuclear ribonucleoprotein L (hnRNPL), creating a new molecule that regulates genetic control of TNF-alphaa potent cytokine that promotes inflammation. The authors named the molecule THRIL, after TNF-alpha and hnRNPL-related immunoregulatory lincRNA.

Noncoding RNAs as key regulators of immune response

Large noncoding RNA corresponds to the parts of the genome that do not code for protein.

"For some time we have known that noncoding regions of RNA play important roles in regulating the immune response to microbial pathogens," said Tariq Rana, Ph.D., senior author of the study and professor in the Sanford Children's Health Research Center and director of the RNA Biology Program at Sanford-Burnham. "When we realized that THRIL functioned to control the TNF-alpha gene, we wanted to see if it mirrors the progression in inflammatory diseases."

Collaborating with Jane Burns, M.D., professor of pediatrics at Rady Children's Hospital and UC San Diego, Rana's team measured THRIL levels in Kawasaki disease samples at different stages of the disease, and found that levels were at their lowest during the acute stage of the diseasewhen TNF-alpha levels are at their highest.

The findings suggest that THRIL could be a novel biomarker for immune activation and a potential target for inflammatory diseases.


'/>"/>

Contact: Susan Gammon
858-795-5012
Sanford-Burnham Medical Research Institute
Source:Eurekalert  

Related biology news :

1. The next era in discovering drugs in natures own medicine cabinet
2. Researchers develop tools for discovering new species
3. Discovering cell surface proteins behavior
4. Protein explains increased asthma severity in children exposed to diesel exhaust from traffic
5. Small protein plays big role in asthma severity
6. Probiotic bacterium lessens severity of Salmonella infections by hoarding iron
7. CSHL geneticists solve mystery of EEC Syndromes variable severity in children
8. Gut microbes could determine the severity of melamine-induced kidney disease
9. Researchers show prebiotic can reduce severity of colitis
10. Exposure to antibiotics linked to severity of allergic asthma: UBC research
11. Gene therapy for human skin disease produces long-term benefits
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Discovering a 'THRIL' that correlates with severity of Kawasaki disease
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
Breaking Biology News(10 mins):
(Date:4/29/2016)... Diego, CA (PRWEB) , ... April 29, 2016 , ... ... Foundation (NSCF) to support the development of a patient-specific stem cell therapy for the ... in the lab of Dr. Jeanne Loring at The Scripps Research Institute in San ...
(Date:4/28/2016)... ... April 28, 2016 , ... Connecticut Innovations ... growing companies, today announced the launch of VentureClash , a $5 million ... , “VentureClash looks to attract the best early-stage companies here in Connecticut, ...
(Date:4/27/2016)... ... ... Shimadzu Scientific Instruments (SSI) will be showcasing a broad ... Expo. Shimadzu’s high-performance instruments enable laboratories to test cannabis products for potency, moisture, ... booth 1021 to learn how Shimadzu’s instruments can help improve QA/QC testing, peak ...
(Date:4/27/2016)... ... April 27, 2016 , ... The ... announce the appointment of John Tilton as Chief Commercial Officer.  Mr. Tilton joined ... of the founding commercial leaders responsible for the commercialization of multiple orphan drug ...
Breaking Biology Technology: